Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | ECPI Global ESG Medical Tech |
| Investment focus | Equity, World, Health Care, Social/Environmental |
| Fund size | EUR 1 m |
| Total expense ratio | 0.31% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | Yes |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 14.49% |
| Inception/ Listing Date | 18 January 2023 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Luxembourg |
| Fund Provider | BNP Paribas Easy |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | BNP PARIBAS SECURITIES SERVICES-LUXEMBOURG BRANCH |
| Investment Advisor | |
| Custodian Bank | BNP PARIBAS, Luxembourg Branch |
| Revision Company | PricewaterhouseCoopers Société Coopérative |
| Fiscal Year End | 20 May |
| Swiss representative | BNP Paribas, Paris, Zurich Branch. |
| Swiss paying agent | BNP PARIBAS, Paris, Zurich Branch |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | Unknown |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| argenx | 2.71% |
| Alnylam Pharmaceuticals | 2.71% |
| IQVIA Holdings | 2.57% |
| Genmab A/S | 2.52% |
| Thermo Fisher Scientific | 2.48% |
| EssilorLuxottica SA | 2.46% |
| HOYA Corp. | 2.42% |
| BeOne Medicines Ltd. | 2.33% |
| Smith & Nephew plc | 2.27% |
| Agilent Technologies | 2.27% |
| Health Care | 91.65% |
| Consumer Discretionary | 2.46% |
| Other | 5.89% |
| Broker | Rating | Order fee | ETF savings plans | |
|---|---|---|---|---|
| 0.99€ | 2934 | View offer* | |
| 0.00€ | 1523 | View offer* | |
| 0.00€ | 1625 | View offer* | |
| 9.95€ | 1557 | View offer* | |
| 6.15€ | 1176 | View offer* |
| YTD | +1.39% |
| 1 month | +2.83% |
| 3 months | +4.07% |
| 6 months | +8.62% |
| 1 year | -2.28% |
| 3 years | - |
| 5 years | - |
| Since inception (MAX) | +2.49% |
| 2024 | +2.87% |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| Volatility 1 year | 14.49% |
| Volatility 3 years | - |
| Volatility 5 years | - |
| Return per risk 1 year | -0.16 |
| Return per risk 3 years | - |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -19.80% |
| Maximum drawdown 3 years | - |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -19.80% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| Euronext Paris | USD | MTUSD | MTUSD FP IMTUS | MTUSD.PA MTUSDINAV=IHSM | BNP Paribas Arbitrage |
| SIX Swiss Exchange | USD | MTUSD | MTUSD SW IMTUS | MTUSD.S MTUSDINAV=IHSM | BNP Paribas Arbitrage |
| XETRA | USD | BJLA | BJLA GY IMTUS | BJLA.DE MTUSDINAV=IHSM | BNP Paribas Arbitrage |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Healthcare Innovation UCITS ETF | 920 | 0.40% p.a. | Accumulating | Sampling |
| iShares Ageing Population UCITS ETF | 536 | 0.40% p.a. | Accumulating | Sampling |
| iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist) | 438 | 0.18% p.a. | Distributing | Full replication |
| Amundi S&P Global Health Care ESG UCITS ETF DR EUR (A) | 336 | 0.18% p.a. | Accumulating | Full replication |
| iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Acc) | 143 | 0.18% p.a. | Accumulating | Full replication |